FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
Center | Date | Time | Location |
---|---|---|---|
CDRH | June 23, 2005 | 9:00 a.m. - 5:00 p.m. | Holiday Inn |
Agenda:
The committee will hear a presentation on the FDA Critical Path Initiative.
The committee will also discuss, make recommendations, and vote on a premarket
approval application for a fetal heart monitoring device that, in addition to
standard features, is used during labor and delivery to measure, display, and
analyze the ST waveform, of the fetal electrocardiogram.
Background material and meeting information will become available no later than one business day before the meeting (Simply scroll down to the appropriate committee heading).
Procedure:
Interested persons may present data, information, or views, orally or in writing,
on issues pending before the committee. Written submissions may be made to the
contact person by June 16, 2005. Oral presentations from the public will be
scheduled between approximately 9:30 a.m. and 10 a.m. and between approximately
3:30 p.m. and 4 p.m.. Time allotted for each presentation may be limited. Those
desiring to make formal oral presentations should notify the contact person
before June 16, 2005, and submit a brief statement of the general nature of
the evidence or arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to make their
presentation. Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical outlets.
FDA welcomes the attendance of the public at its advisory committee meetings
and will make every effort to accommodate persons with physical disabilities
or special needs. If you require special accommodations due to a disability,
please contact AnnMarie Williams, Conference Management Staff, at 240-276-0450,
ext. 113, at least 7 days in advance of the meeting.
Contact Person:
Michael Bailey, Center for Devices and Radiological Health
(HFZ-470), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD
20850, 301-594-1180.
Advisory Committee Telephone Information Line:
Please call the Information Line for up-to-date information on this
meeting, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512524.